At close: December 13 at 4:00:00 PM EST
After hours: 7:16:32 PM EST
Breakdown
12/31/2023
12/31/2022
Total Assets
5,256.0000
9,333.0000
Total Liabilities Net Minority Interest
17,312.0000
16,412.0000
Total Equity Gross Minority Interest
-12,056.0000
-7,079.0000
Total Capitalization
-15,476.0000
-10,665.0000
Common Stock Equity
-15,476.0000
-10,665.0000
Capital Lease Obligations
171.0000
271.0000
Net Tangible Assets
-15,476.0000
-10,665.0000
Working Capital
2,783.0000
7,229.0000
Invested Capital
-15,476.0000
-10,665.0000
Tangible Book Value
-15,476.0000
-10,665.0000
Total Debt
171.0000
271.0000
Share Issued
11,180.0310
8,151.6500
Ordinary Shares Number
11,180.0310
8,151.6500
12/31/2022 - 4/7/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PCSA Processa Pharmaceuticals, Inc.
1.1100
-11.20%
PBM Psyence Biomedical Ltd.
1.8500
-9.31%
PALI Palisade Bio, Inc.
1.7700
-25.00%
CRDF Cardiff Oncology, Inc.
3.9200
+19.88%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8100
+2.26%
TRVI Trevi Therapeutics, Inc.
4.1700
+15.83%
IPHA Innate Pharma S.A.
3.0200
+96.10%
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
CMRX Chimerix, Inc.
2.9500
+0.34%
DBVT DBV Technologies S.A.
3.5700
-7.03%